Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer

Inclusion Criteria

• •DISEASE CHARACTERISTICS:
• •Histologically confirmed colorectal cancer
• •* Radiological documentation of disease is preferred, but not required
• •PATIENT CHARACTERISTICS:
• •Karnofsky performance status 70-100%
• •Life expectancy ≥ 3 months
• •WBC ≥ 3,000/mm³
• •Neutrophil count ≥ 1,500/mm³
• •Platelet count ≥ 100,000/mm³
• •Serum creatinine normal
• •Bilirubin ≤ 1.5 times upper limit of normal (ULN)
• •AST/ALT \< 2 times ULN
• •Not pregnant or nursing
• •Fertile patients must use effective contraception during and for 1 month after completion of study therapy
• •No medical conditions that might prevent full participation in protocol-required testing or follow-up
• •No institutionalized patients (e.g., in prisons or mental health institutions)
• •PRIOR CONCURRENT THERAPY:
• •No concurrent chemotherapy or treatments that would compromise the safety and efficacy of protocol assessments